key: cord-0010543-vyg1t4zx
authors: Dutronc, Y.; Porcelli, S.A.
title: The CD1 family and T cell recognition of lipid antigens
date: 2002-12-18
journal: Tissue Antigens
DOI: 10.1034/j.1399-0039.2002.600501.x
sha: 821ac03b4b663d71f63557815da2081a9f8ef4bd
doc_id: 10543
cord_uid: vyg1t4zx

Abstract: For many years it was thought that T lymphocytes recognized only peptide antigens presented by MHC class I or class II molecules. Recently, it has become clear that a wide variety of lipids and glycolipids are also targets of the T cell response. This novel form of cell‐mediated immune recognition is mediated by a family of lipid binding and presenting molecules known as CD1. The CD1 proteins represent a small to moderate sized family of β2‐microglobulin‐associated transmembrane proteins that are distantly related to MHC class I and class II molecules. They are conserved in most or all mammals, and control the development and function of T cell populations that participate in innate and adaptive immune responses through the recognition of self and foreign lipid antigens. Here we review the current state of our understanding of the structure and function of CD1 proteins, and the role of CD1‐restricted T cell responses in the immune system.

standing of the immune response because it allows the T cell system to recognize and respond to a class of antigens that is completely distinct from those that are presented by MHC class I and II. Instead of presenting peptides, the CD1 proteins bind and present lipid and glycolipid antigens of both self and foreign origin (1).

Studies of this novel system for immune recognition now point to important roles in the processes of augmenting and regulating innate and adaptive immunity. Here we review recent developments in the study of CD1 molecules and the T cell populations that are controlled by them, and discuss their known and potential contributions to the immune response.

The CD1 molecules comprise a small to moderate sized family of b2-microglobulin-associated, transmembrane glycoproteins. They are structurally related to the MHC-class I molecules, but are encoded by genes that are unlinked to the MHC locus and lack the extensive polymorphism of classical MHC encoded antigen presenting molecules. Variable numbers of CD1 genes have been found in all mammals studied to date, and these have been extensively characterized in several species including man, mouse, rat, rabbit and guinea pig (1, 2). It is currently not known whether CD1 genes exist in nonmammalian vertebrates such as birds or fish.

In humans, the CD1 family has five members, designated as CD1a, CD1b, CD1c, CD1d and CD1e proteins. Among these, it has been proposed that two or perhaps three distinct groups of CD1 proteins can be discerned, based on sequence homologies, sites of expression and function. Thus, CD1a, CD1b and CD1c are typically classified as group 1 CD1 proteins, while the more divergent CD1d protein comprises group 2 (3). The CD1e protein has not been extensively studied, but it is intermediate in terms of its homology to group 1 and group 2 CD1 proteins, and appears to be unique in that its expression may be confined exclusively to intracellular compartments of myeloid lineage cells (4). Thus, we currently support the classification of CD1e as group 3 CD1. Most species studied to date show the presence of genes for multiple homologs of the human group 1 CD1 proteins, the exception being mice and rats, which only have genes encoding CD1d-like proteins. The group 2 CD1 proteins appear to be even more highly conserved, and have been found in all mammals for which CD1 genes or proteins have been characterized in detail, with the exception of the guinea pig (Table 1) .

Tissue Antigens 2002: 60: 337-353

Analysis of the tissue distribution of CD1 molecules provides further support for the classification of CD1 molecules into at least two distinct groups. The distribution of group 1 CD1 molecules is relatively restricted, with strong expression mostly limited to immature cortical thymocytes and a variety of specialized antigen-presenting cells, most notably myeloid lineage dendritic cells and a subset of B lymphocytes (1). In contrast, human and murine CD1d molecules are widely expressed on hematopoietic cells (5, 6) and have also been detected on a variety of nonhematopoietic cell types, in particular epithelial cells (7, 8) .

An additional aspect of the diversity of CD1 molecules resides in their divergent cellular distribution (Fig. 1) . The following is a summary of the differences in subcellular localization and trafficking that have been reported for the various CD1 isoforms.

At steady state, human CD1a molecules are prominently expressed at the plasma membrane of blood monocyte-derived dendritic cells (DC) and epidermal Langerhans cells (LC). They are absent from the late endosomal and lysosomal compartments, but can be detected in the early/recycling endosomes (9). Analysis of CD1a trafficking in freshly extracted human LC suggests that CD1a molecules present at the cell surface spontaneously internalize via clathrin-coated vesicles. Most likely, they are rapidly distributed to the early/sorting endosomes and delivered to early/recycling endosomes, and from this site they recycle back to the plasma membrane (10). It is still unclear which mechanisms drive the intracellular trafficking of CD1a, as its short intracytoplasmic tail does not contain any recognizable sorting motif, in contrast to most other CD1 molecules.

Human monocyte-derived DC express high levels of CD1b at their surface, but the molecule is also present in endosomes, lysosomes and the closely related MHC class II compartments (MIICs) of specialized antigen presenting cells (11, 12) . After synthesis, CD1b molecules are transported rapidly to the cell surface via the secretory pathway, and from this site they are then internalized by clathrinmediated endocytosis. This internalization is dependent on a tyrosine-based motif of the cytoplasmic tail (YXXF, where Y is tyrosine, X is any amino acid, and F is a bulky hydrophobic residue), prob-ably through its interaction with cytosolic adaptor protein complex 13) . Subsequent sorting to the late endosomal compartment may be dependent on interaction of the CD1b tail with another adaptor protein 14) . It should be noted that these features of trafficking and localization have been described for human CD1b, but may not apply in all cases to orthologues of this protein in other species. For example, the guinea pig expresses several proteins that appear to be closely related in structure to human CD1b, but one of these (gpCD1b3) shows a pattern of cellular localization that is similar to that of human CD1a (15) .

The distribution of human CD1c partially overlaps those of CD1a and CD1b molecules. CD1c is expressed at the cell surface and most likely is internalized by clathrin-mediated endocytosis, similar to CD1b.

CD1c is abundantly present in the early/recycling compartment, but also colocalizes partially with CD1b in late endosomes (12). Despite the presence of a tyrosine-based endosomal targeting motif very similar to the one present in CD1b, CD1c does not accumulate to any consistently appreciable extent in the MIIC compartment, probably because it cannot interact strongly with AP-3 (13, 14).

The steady state localizations and trafficking of human and murine CD1d molecules are very similar to those of human CD1b, with expression at the plasma membrane after synthesis and progressive accumulation in lysosomes and MIIC compartments, mediated by a tyrosine-based internalization motif (16). However, two recent studies revealed the existence of alternative trafficking mechanisms for both murine and human CD1d, through their association, respectively, with the MHC class II-associated invariant chain (Ii) and with MHC class II molecules themselves (17, 18) . 

Foreign and self antigens presented by CD1

Because of the resemblance between CD1 and MHC-encoded antigen presenting molecules, early studies on the function of CD1 sought to demonstrate a role in specific recognition by T cells. A critical step was made with the isolation of a CD1b-restricted human T cell line that was specific for a foreign antigen contained in Mycobacterium tuberculosis. The direct isolation and characterization of the mycobacterial substance presented to this T cell line led to the initial realization that CD1-presented antigens are predominantly or exclusively lipid in nature (20).

The first CD1-presented antigens to be precisely identified, all of which are presented by CD1b, were free mycolic acid, lipoarabinomannan (LAM) and glucose monomycolate (GMM), all major components of mycobacterial cell walls that do not have close structural homologs in mammalian cells ( Fig. 3 ) (21). Additional studies revealed that other human group 1 CD1 molecules, CD1a and CD1c, could also mediate presentation of mycobacterial lipid antigens.

While the identities of the foreign lipid antigens presented by CD1a are still not known, one prominent CD1c-presented antigen from mycobacteria has been isolated and identified as a bl-mannosylphosphoisoprenoid (22). While these mycobacterial lipid antigens are in most cases structurally divergent from mammalian lipids, it has recently been demonstrated that a variety of mammalian glycosphingolipids are also presented by human group 1 CD1 molecules ( Fig. 3 ) (23, 24). This fascinating finding suggests that CD1-presented ligands are not solely, or even predominantly, molecular patterns expressed exclusively in microbial pathogens. This is important, because it indicates that in many situations the response to lipid antigens through CD1 presentation may represent a form of adaptive rather than innate immunity, requiring a fine distinction between self and foreign lipid antigens and a mechanism for maintaining tolerance to the former.

To date, no microbial pathogen-associated antigen presented by

CD1d has been isolated. The best described CD1d-presented antigens are synthetic glycosylceramides, and in particular a form of a- of aGalCer in mammalian tissues or in relevant microbial pathogens have been unsuccessful. It thus seems unlikely that this compound represents a true antigen for natural CD1d-restricted immune responses, and efforts are still being made to identify the natural microbial or self antigens that are presented by CD1d. While it is generally accepted that the frequent CD1d-restricted autoreactivity observed among murine NK T cells is likely to be due to recognition of self-antigens presented on CD1d, the precise identity of these putative natural self ligands remains unknown. Some initial clues toward the identification of such self ligands may be provided by reports that CD1d restricted NK T cells can be activated by natural and synthetic glycosyl phosphatidylinositol (GPI) (28) and other common phospholipids including phosphatidylinositol (PI), phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) (29) .

These studies corroborate an earlier claim that GPI was the major natural ligand that could be identified in fractions of low molecular weight material extracted from murine CD1d proteins (30). Together, these findings on the binding of endogenous lipids by CD1 have suggested a model in which some endogenous lipids might play a chaperon-like role during the biosynthesis of CD1 molecules (Fig. 4) .

As recently described for GPI and PI in the case of CD1d molecules, the binding of these endogenous lipids is likely to occur in the ER, shortly after association of the CD1 heavy chain with b2-microglobulin, and would serve to stabilize the molecule and protect the binding site from inappropriate interactions until it reached the cell surface (31, 32) . After internalization of CD1 molecules, the chaperon lipids would subsequently be exchanged for other endogenous glycolipids or exogenous lipids present in endocytic compartments.

Interactions between CD1 proteins and their lipid ligands

As illustrated in Fig. 3 , all identified CD1-associated antigens are amphipathic lipid molecules, consisting of a hydrophilic head with polar or charged groups and a hydrophobic tail composed of one or two straight hydrocarbon chains. The molecular basis for TCR recognition of lipids in the context of CD1 presentation seems to parallel in many aspects the recognition of MHC/peptide complexes.

Substantial insight in this area was provided by the crystal structure of the mouse CD1d protein (33) . This revealed that CD1d molecules, like MHC class I proteins, possess an antigen-binding groove formed by the al and a2 domains. However, the binding groove in

CD1d is narrower at its opening and deeper than the peptide-binding groove in MHC molecules. In addition, it is formed mostly from two relatively large pockets (referred to as Aƒ and Fƒ) that have a hydrophobic surface. Thus, the ligand-binding groove of CD1d appears ideally suited to bind hydrophobic molecules, such as the alkyl tails of lipids and glycolipids. The general features of the MHC class I-like fold with a large hydrophobic binding groove is likely to be conserved in all CD1 proteins, a view which is supported by recent structural data from the X-ray crystallography of human CD1b molecules (34).

Based on the structure of CD1 molecules and the known ligands The sources of the structures illustrated are stated on the right, along with the CD1 isoform(s) known to present them. Top: mycolates. These are a-branched, b-hydroxy fatty acids produced by bacteria belonging to the order Actinomycetales (e.g., mycobacteria, nocardia, corynebacteria and rhodococci). CD1b is known to present both free and glycosylated forms of these, including a wide variety of different mycolate structures distinguished by variations in their chain lengths, the presence or absence of double bonds or cyclopropyl groups, and the presence or absence of oxygen containing substitutions (R group) near the distal end of the longer meromycolate branch. Illustrated are a dicyclopropanated C80 mycolate lacking an R group (a-mycolic acid), and a typical methoxy-mycolate of M. tuberculosis. Two of the many potential forms of glucose monomycolate are illustrated, both of which are known to be presented by human CD1b. Center: glycosphingolipids. The prototype for this class is the marine spongederived glycolipid (2S,3S,4R)-1-O-(a-D-galactopyranosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, generally referred to as a-galactosyl ceramide. More recent studies have demonstrated CD1-restricted presentation of several mammalian glycosphingolipids, two of which are illustrated. Bottom: glycophospholipids. Mycobacterial forms of this class were initially demonstrated to be presented by human CD1b, including the relatively simple phosphatidylinositol dimannoside structure shown and more heavily glycosylated versions of this basic structure such as lipoarabinomannans of M. tuberculosis and M. leprae. Mammalian phosphatidylinositol and more highly glycosylated versions of this structure (glycosylphosphatidylinositols (GPI)) have been shown to bind to mouse and human CD1d proteins, although evidence for their recognition by T cells is currently limited, The fully saturated b1-mannosyl phosphoisoprenoids isolated from M. tuberculosis and M. avium are unique at present as the only CD1-presented antigens bearing a single alkyl chain tail. 

Relatively little known is about the molecular details of antigen processing for lipid presentation, and the conditions that facilitate the loading of these ligands onto the CD1 proteins are mostly undetermined. Nonetheless, through combined analyzes of the cellular trafficking and of the requirements for presentation of various CD1presented antigens, some insight into these questions can be gathered for each CD1 isoform that is known to function in antigen presentation.

Analysis of a human CD1a-restricted T cell response to an unidentified mycobacterial lipid antigen suggests that antigen presentation requires endocytosis, but does not require endosomal acidification (9). Although the analysis of CD1a is limited to a single T cell line and a single unidentified lipid antigen at present, it appears most likely that this CD1 protein may use the early/recycling endosomes as its main loading compartment.

Presentation of the long chain (ϳC80) mycobacterial glycolipid GMM (Fig. 3 ) by human CD1b is completely inhibited by fixation of the antigen presenting cells (APC) with glutaraldehyde prior to antigen pulsing, or by treatment of APC with concanamycin A or chloroquine (9, 12). In AP-3 deficient cells, the presentation of GMM is altered but not completely eliminated, suggesting that while lysosomes and MIIC compartments are probably the main sites of loading, some CD1b molecules might bind antigens earlier in the endocytic pathway (14).

Recent studies suggest that the mechanisms of antigen binding and presentation by CD1b may be more complex than originally thought and highly dependent on the chemical structure of a particular lipid antigen, specifically the length of its alkyl chains (45). where they can be loaded on CD1b. In contrast, nonphagocytic

CD1b π cells such as thymocytes might preferentially present short chain self glycolipids, loaded during CD1b trafficking through the intracellular compartments to the cell surface or at the plasma membrane. In this way, they could provide self-ligands for thymic selection of CD1-restricted T cells.

Antigen loading onto CD1c probably occurs in an endosomal compartment, as one study has found that the CD1c-restricted T cell response is reduced if the APC are fixed before being pulsed with the antigen (46). However, presentation of the mycobacterial b1-man- Cer was detectable at neutral pH, it was optimal at pH 4 with a 4fold increase in the NKT cell response (29) . The absence of a strong or absolute requirement for acidification suggests that the loading of aGalCer could occur at various sites in the endosomal pathway, but probably more efficiently in acidified compartments.

Glycolipids with long alkyl chains or with large complex carbohydrate moieties may be too large to fit properly in the binding groove of CD1 molecules in a way that allows their recognition by T hydrophilic keto or methoxy group on the long alkyl chain (Fig. 3) .

This observation suggests that a folding of the alkyl chain occurs during the binding to CD1b that brings these two distant hydrophilic components into close proximity to allow them to form a combinatorial epitope. Interestingly, the recent crystal structure data on CD1b supports the possibility that the groove of this molecule could potentially hold a very long chain mycolic acid in a folded configuration that might allow such positioning of the two hydrophilic components at the TCR binding interface (34).

Group 1 CD1-restricted T cells reactive with bacterial antigens

The first group 1 CD1-restricted T cell lines to be described were all derived from CD4 -CD8 -T cells, but subsequent studies demonstrated that CD1-restricted T cells could also be found among CD8 π and CD4 π T cells. Most human group 1 CD1-restricted T cells have been derived against mycobacterial antigens, and these invariably produce large amounts of IFNg and extremely low or undetectable amounts of IL-4 when cocultured with antigen-pulsed dendritic cells. In addition, they generally show moderate to strong cytolytic activity against CD1 π target cells, such as dendritic cells that have been pulsed with mycobacterial antigens or infected with live mycobacteria (50). These functional characteristics of group 1 CD1-re- The investigation of group 1 CD1 in host immunity against infection has been hampered by the absence of an appropriate animal model. As mentioned previously, the muroid rodents (mice and rats) lack group 1 CD1 genes, as these were probably lost by deletion during the evolution of these species (2). The identification and characterization of guinea pig group 1 CD1 proteins has recently enabled studies demonstrating that a CD1-restricted T cell response against M. tuberculosis lipid antigens can be induced by immunization in this animal. Therefore, the guinea pig may eventually provide a suitable model in which to study group 1 CD1-restricted immune responses to mycobacterial pathogens in vivo (53) .

Like ab T lymphocytes, gd T cells express a TCR generated by somatic gene rearrangements, but with limited combinatorial diver- Group 2 CD1-restricted T cells

The main population of CD1d-restricted T cells is the aGalCer-reactive Va14J18 π NK T cells in mice, and the homologous Va24Ja15 π T Cells in humans. One of the first identified functional properties of NK T cells was their ability to rapidly secrete both Th1 and Th2 cytokines in vitro in response to TCR stimulation without the need for priming, suggesting that they might have an important influence on the nature of the adaptive immune response through polarization of CD4 π T cells to Th1 or Th2 effectors (27).

A breakthrough in the analysis of NK T cells occurred with the discovery of the stimulatory activity of aGalCer, which created the possibility of specifically activating NK T cells in vivo (25, 26) . In mice, injection of aGalCer induces a series of cellular activation events that have been referred to as the 'adjuvant cascade ' (27) . This begins with the rapid release of IL-4 and IFNg by NK T cells after

CD1d-mediated presentation of aGalCer, which directly stimulates NK cells and B cells, and potentially activates and influences the differentiation of conventional CD4 π and CD8 π T cells (Fig. 5) .

After aGalCer injection, NK T cells rapidly disappear from the liver and spleen within 3-12 h, most probably as the result of acti-

in the liver and the spleen after two or three days but their numbers remain lower than in control mice for several weeks (57, 58 

As NK T cells can be studied in mouse models, it has been possible to assess their potential relevance in vivo in a wide variety of murine models of infectious disease. The following is a brief overview organized with respect to the broad categories of different pathogens that have been examined. in HBV-transgenic mice. This effect is associated with the production of IFNg and IFNa/b and with activation of NK cells but not of conventional T cells (67) . In a different model of hepatitis B infection, Baron et al. showed that a distinct population of CD1d-re-stricted T cells that were not reactive to aGalCer was activated in response to hepatocytes expressing HBV antigens, and that this response produced hepatitis (68) . Interestingly, a Th1-biased CD1drestricted T cell population expressing diverse TCR was also iden- 

The antitumor activity of aGalCer, observed in several murine models depends on the activation of NK T cells as it is abolished in CD1-deficient mice (reviewed in (71)). However, NK T cells are not believed to directly mediate the cytotoxicity against tumor cells that is induced by a GalCer in most tumor models, which is actually mediated by the NK cells (58). The critical elements of this activity of a GalCer are the production of IFNg by NK T cells and of IL-12 by dendritic cells, which amplifies IFNg production. The cytotoxic activity of NK cells that is induced by aGalCer appears to be perforin-independent and FasL-independent. NK T cells can also be activated to produce IFNg directly by IL-12, and thus participate in the anti-metastatic activities of this cytokine (71). 

Defects in NK T cell numbers and cytokine production have been reported in several animal models of autoimmune diseases and in human subjects with systemic sclerosis, type 1 diabetes, multiple sclerosis, and rheumatoid arthritis (reviewed in (75)). It has been shown that many mouse autoimmune disease models depend on pathogenic Th1 cells, and this is believed to be the case for their human counterparts also. The observation that aGalCer administration in vivo can give rise to Th2 polarized NK T cells suggests that this compound could be used to influence the course of these diseases. This idea has been evaluated in two experimental models to date, experimental autoimmune encephalomyelitis (EAE) and type In NOD mice, repeated injections of aGalCer delay the onset and reduce the incidence of the diabetes (78) (79) (80) . The protective effect of aGalCer treatment is associated with accumulation of NK T cells in the pancreas and the pancreatic lymph nodes, and the recruitment of tolerogenic myeloid DC in the pancreatic lymph nodes (80). After the onset of insulitis, aGalCer treatment does not protect against the development of diabetes if injected alone, but coadministration with IL-7 restores the efficacy of treatment (79).

It is now clear from studies of the CD1 family that lipids and glycolipids represent relevant targets for T cell responses. As the missing pieces of information in our understanding of CD1 and the T cells that recognize it begin to be filled in, the appreciation of the potential role of lipid antigen recognition in the immune response continues to grow. Given the broad range of antigens in this chemical class, it seems likely that adaptive T cell mediated immune responses against foreign microbial lipids could represent important targets for generating resistance against certain pathogens. This may be particularly true for highly successful pathogens like M.

tuberculosis or Plasmodium falciparum, which have clearly evolved multiple strategies to evade or subvert immune recognition. The same may be true for certain tumors, in which modified or aberrantly expressed glycolipids could represent a major basis for immune recognition. These aspects of the CD1-restricted response are thus likely to have relevance to immunotherapies of infectious and neoplastic disease through novel approaches to vaccine development.

In addition to their role in the adaptive immune response, CD1restricted T cell responses also appear to be intimately connected to the generation of innate immunity. This is particularly evident from the many studies of CD1d-restricted NK T cells, a highly conserved innate-like lymphocyte in most or possibly all mammals that has the ability to trigger a powerful adjuvant cascade. While this can heighten inflammation and microbial resistance under some circumstances, the tremendous immunoregulatory potential of these T cells in other cases demonstrates their potential utility for controlling autoimmune and chronic inflammatory diseases. Understanding how to manipulate these T cells precisely through their recognition of CD1-presented lipid ligands is likely to provide the key to exploiting their considerable potential as agents for promoting beneficial immunity and treating disease.

CD1d-restricted antigen-presenting molecules for T cell rec-Bonifacino JS, Brenner MB. Failure of trafmouse Va14 and human Va24 T cells: ognition of lipids and glycolipids. Annu Rev ficking and antigen presentation by CD1 in lymphocytes of innate immunity

AP-3-deficient cells

The molecular biology 28

CD1d-restricted immunoglobulin G forma-3. Characterization of guinea-pig group 1

tion to GPI-anchored antigens mediated by Two classes of CD1 genes

CD1 molecule expressed in dendritic cells. J autoreactive T cells have diverse patterns of 30

279: CD1 is mainly expressed on hemopoietic-17

CD1d CD1d1 with cellular phospholipids occurs in structure and regulation on human thymothe invariant chain. Immunity 2001: 15: the endoplasmic reticulum

Re-7. cellular trafficking of human CD1d by as-Blumberg RS, Terhorst C, Bleicher P et al. cycling CD1d1 molecules present endoge-Expression of a nonpolymorphic MHC sociation with MHC class II molecules. nous antigens processed in an endocytic class I-like molecule, CD1D, by human intes-EMBO J 2002: 21: 1650-60. compartment to NKT Cells

Crystal structure of pression of CD1d by keratinocytes in psomunity 2001: 15: 909-19. mouse CD1: an MHC-like fold with a large riasis and CD1d-dependent IFN-gamma pro-20

ture of human CD1b with bound ligands at Separate pathways for antigen presen-21. Moody DB, Besra GS. Glycolipid targets of 2.3 A, a maze for alkyl chains. Nat Immunol tation by CD1 molecules. Immunity 1999: CD1-mediated T-cell responses

CD1a molecules traffic through the early CD1c-mediated T-cell recognition of isopentation of lipid antigens

Langerhans cells

Cytoplasmic tail-dependent localization of Kappos L, De Libero G

forms survey different intracellular comsame glycolipid by different CD1 molecules. 38. Melian A, Watts GF, Shamshiev A et al. partments for the presentation of microbial

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

Exley M et Fine specificity of TCR complementarity-demediated T cell recognition of a glycolipid al. CD1d-dependent macrophage mediated termining region residues and lipid antigen antigen generated from mycobacterial lipid clearance of Pseudomonas aeruginosa from hydrophilic moieties in the recognition of a and host carbohydrate during infection

Exp Med

Struccells in IL-12 production during Salmonella tural requirements for antigen presentation rosy lesions: correlation with effective host infection

Warren ficient in CD1D or TAP1 to infection with K, Naidenko OV, Kronenberg M. Natural sponses in guinea pigs by immunization Mycobacterium tuberculosis

Natural and syn-MHC class 1b, CD1d1 molecules behave like 42. thetic non-peptide antigens recognized by Chiu YH

nize self-antigens loaded in different cellular 55

Natural killer T cell activation inhibits 10. man T lymphocytes: analysis with periphhepatitis B virus replication in vivo

Activation of a nonautoreactive T cell receptor families. J Exp recognition of CD1 by g/d T cells: impliclassical NKT cell subset in a transgenic Med 2001: 193: 893-904. cations for innate immunity

Cutting recognition of a-galactosylceramide by hu-Tracking the response of natural killer T edge: compartmentalization of Th1-like nonman CD4 π and CD8ab π T lymphocytes. J cells to a glycolipid antigen using CD1d invariant CD1d-reactive T cells in hepatitis Immunol 2002: 168: 5514-20. tetramers

length controls antigen entry into endosomal Mechanisms of the antimetastatic effect in 70. Gonzalez-Aseguinolaza G, Van Kaer L, and nonendosomal pathways for CD1b the liver and of the hepatocyte injury in-Bergmann CC et al. Natural killer T cell presentation

190: killer T (NKT) cell developmental pathway urveillance of methylcholanthrene-induced 1069-80

interaction of CD1b with lipoglycan anti-2002: 195: 835-44. NKT cell-mediated repression of tumor imgens

Teyton IL, munosurveillance by IL-13 and the IL-4R-49

Cutting edge: CD1d deficiency Ullrich SE. Immune suppression and skin 50. impairs murine host defense against the spi-Gumperz JE, Brenner MB. CD1-specific T cancer development: regulation by NKT cells in microbial immunity. Curr Opin Imrochete, Borrelia burgdorferi

Actitential targets for autoimmune disease thersynthetic glycolipid prevents autoimmune vation of natural killer T cells a-galactosylapy?

1801-natural killer T-cell ligand a-galactosylcer-Activation of CD1d-restricted T cells protects 11. amide prevents autoimmune diabetes in NOD mice from developing diabetes by non-obese diabetic mice